These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 1474179

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH, Jefferson JW, Rosenfeld R, Gutzmann LD, March JS, Barklage NE.
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R, McLeod DR, Zimmerli WD, Hipsley PA.
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [Abstract] [Full Text] [Related]

  • 6. Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.
    Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.
    J Clin Psychiatry; 1994 Jul; 55(7):301-5. PubMed ID: 8071291
    [Abstract] [Full Text] [Related]

  • 7. A clomipramine dosage reduction study in the course of long-term treatment of obsessive-compulsive disorder patients.
    Pato MT, Hill JL, Murphy DL.
    Psychopharmacol Bull; 1990 Jul; 26(2):211-4. PubMed ID: 2236458
    [Abstract] [Full Text] [Related]

  • 8. Clomipramine treatment of obsessive compulsive symptomatology in schizophrenic patients.
    Zohar J, Kaplan Z, Benjamin J.
    J Clin Psychiatry; 1993 Oct; 54(10):385-8. PubMed ID: 7903293
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.
    McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.
    J Clin Psychopharmacol; 1993 Oct; 13(5):354-8. PubMed ID: 8227493
    [Abstract] [Full Text] [Related]

  • 12. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
    DeVeaugh-Geiss J, Landau P, Katz R.
    Psychopharmacol Bull; 1989 Oct; 25(1):36-40. PubMed ID: 2672070
    [Abstract] [Full Text] [Related]

  • 13. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.
    McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR.
    J Clin Psychopharmacol; 1991 Jun; 11(3):175-84. PubMed ID: 1820757
    [Abstract] [Full Text] [Related]

  • 14. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
    Sevincok L, Topuz A.
    J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
    [Abstract] [Full Text] [Related]

  • 15. Worldwide use of clomipramine.
    Trimble MR.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():51-4; discussion 55-8. PubMed ID: 2199435
    [Abstract] [Full Text] [Related]

  • 16. Predictors of drug treatment response in obsessive-compulsive disorder.
    Ravizza L, Barzega G, Bellino S, Bogetto F, Maina G.
    J Clin Psychiatry; 1995 Aug; 56(8):368-73. PubMed ID: 7635854
    [Abstract] [Full Text] [Related]

  • 17. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
    O'Sullivan G, Noshirvani H, Marks I, Monteiro W, Lelliott P.
    J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
    [Abstract] [Full Text] [Related]

  • 18. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M, Robbe-Grillet P, Milliery M, Pham S, Amireche S, Fanget F, Guerin J, Cottraux J.
    Encephale; 2001 Apr; 27(3):229-37. PubMed ID: 11488253
    [Abstract] [Full Text] [Related]

  • 19. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
    Hantouche EG, Bouhassira M, Lancrenon S.
    Encephale; 2000 Apr; 26(6):73-83. PubMed ID: 11217541
    [Abstract] [Full Text] [Related]

  • 20. Double-blind controlled study in phobias and obsessions.
    Karabanow O.
    J Int Med Res; 1977 Apr; 5 Suppl 5():42-8. PubMed ID: 340306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.